Siu, Lisa L P <br/><br/>
Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas.  [electronic resource] 

 -  British journal of haematology  Jul 2003 
 - 70-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2141.2003.04396.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--genetics<br/>CpG Islands--genetics<br/>DNA Methylation<br/>DNA, Neoplasm--genetics<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Killer Cells, Natural<br/>Lymphoma, T-Cell--diagnosis<br/>Male<br/>Middle Aged<br/>Neoplasm, Residual<br/>Nose Neoplasms--diagnosis<br/>Polymerase Chain Reaction--methods<br/>Promoter Regions, Genetic--genetics